Global Swine Reproductive and Respiratory Syndrome Vaccine Market Growth 2022-2028
As the global economy mends, the 2021 growth of Swine Reproductive and Respiratory Syndrome Vaccine will have significant change from previous year. According to our latest study, the global Swine Reproductive and Respiratory Syndrome Vaccine market size is USD million in 2022 from USD 415.2 million in 2021, with a change of % between 2021 and 2022. The global Swine Reproductive and Respiratory Syndrome Vaccine market size will reach USD 839.4 million in 2028, growing at a CAGR of 10.6% over the analysis period.
The United States Swine Reproductive and Respiratory Syndrome Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Swine Reproductive and Respiratory Syndrome Vaccine market, reaching US$ million by the year 2028. As for the Europe Swine Reproductive and Respiratory Syndrome Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Swine Reproductive and Respiratory Syndrome Vaccine players cover ASCENT CORPORATION, Boehringer-Ingelheim, MSD Animal Health, and SPAH, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Swine Reproductive and Respiratory Syndrome Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Active Vaccine
Inactivated Vaccines
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Government Tender
Market Sales
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
ASCENT CORPORATION
Boehringer-Ingelheim
MSD Animal Health
SPAH
Ceva
Chengdu TECH-BANK Biological Products Co,.Ltd
ringpu
QILU ANIMAL HEALTH PRODUCTS CO.,LTD
DAHUANONG
CAVAC
Komipharm
Agrovet
Bioveta
JINYU BIO-TECNOLOGY CO.,LTD
Phibro Animal Health
ANHUI TIANKANG(GROUP)SHRES O., LTD
Zoetis
WINSUN BIO
PULIKE BIOLOGICAL ENGINERING,INC.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Swine Reproductive and Respiratory Syndrome Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Swine Reproductive and Respiratory Syndrome Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Swine Reproductive and Respiratory Syndrome Vaccine Segment by Type
2.2.1 Active Vaccine
2.2.2 Inactivated Vaccines
2.3 Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type
2.3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Sale Price by Type (2017-2022)
2.4 Swine Reproductive and Respiratory Syndrome Vaccine Segment by Application
2.4.1 Government Tender
2.4.2 Market Sales
2.5 Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application
2.5.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Sale Price by Application (2017-2022)
3 Global Swine Reproductive and Respiratory Syndrome Vaccine by Company
3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Breakdown Data by Company
3.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Company (2020-2022)
3.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Sale Price by Company
3.4 Key Manufacturers Swine Reproductive and Respiratory Syndrome Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Swine Reproductive and Respiratory Syndrome Vaccine Product Location Distribution
3.4.2 Players Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Swine Reproductive and Respiratory Syndrome Vaccine by Geographic Region
4.1 World Historic Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Annual Revenue by Geographic Region
4.2 World Historic Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Annual Revenue by Country/Region
4.3 Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth
4.4 APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth
4.5 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth
4.6 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth
5 Americas
5.1 Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country
5.1.1 Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2017-2022)
5.1.2 Americas Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2017-2022)
5.2 Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type
5.3 Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region
6.1.1 APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2017-2022)
6.1.2 APAC Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2017-2022)
6.2 APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type
6.3 APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine by Country
7.1.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2017-2022)
7.1.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2017-2022)
7.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type
7.3 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine by Country
8.1.1 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type
8.3 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Swine Reproductive and Respiratory Syndrome Vaccine
10.3 Manufacturing Process Analysis of Swine Reproductive and Respiratory Syndrome Vaccine
10.4 Industry Chain Structure of Swine Reproductive and Respiratory Syndrome Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Swine Reproductive and Respiratory Syndrome Vaccine Distributors
11.3 Swine Reproductive and Respiratory Syndrome Vaccine Customer
12 World Forecast Review for Swine Reproductive and Respiratory Syndrome Vaccine by Geographic Region
12.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Forecast by Region
12.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Forecast by Region (2023-2028)
12.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Swine Reproductive and Respiratory Syndrome Vaccine Forecast by Type
12.7 Global Swine Reproductive and Respiratory Syndrome Vaccine Forecast by Application
13 Key Players Analysis
13.1 ASCENT CORPORATION
13.1.1 ASCENT CORPORATION Company Information
13.1.2 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
13.1.3 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 ASCENT CORPORATION Main Business Overview
13.1.5 ASCENT CORPORATION Latest Developments
13.2 Boehringer-Ingelheim
13.2.1 Boehringer-Ingelheim Company Information
13.2.2 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
13.2.3 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Boehringer-Ingelheim Main Business Overview
13.2.5 Boehringer-Ingelheim Latest Developments
13.3 MSD Animal Health
13.3.1 MSD Animal Health Company Information
13.3.2 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
13.3.3 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 MSD Animal Health Main Business Overview
13.3.5 MSD Animal Health Latest Developments
13.4 SPAH
13.4.1 SPAH Company Information
13.4.2 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
13.4.3 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 SPAH Main Business Overview
13.4.5 SPAH Latest Developments
13.5 Ceva
13.5.1 Ceva Company Information
13.5.2 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
13.5.3 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Ceva Main Business Overview
13.5.5 Ceva Latest Developments
13.6 Chengdu TECH-BANK Biological Products Co,.Ltd
13.6.1 Chengdu TECH-BANK Biological Products Co,.Ltd Company Information
13.6.2 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
13.6.3 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Chengdu TECH-BANK Biological Products Co,.Ltd Main Business Overview
13.6.5 Chengdu TECH-BANK Biological Products Co,.Ltd Latest Developments
13.7 ringpu
13.7.1 ringpu Company Information
13.7.2 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
13.7.3 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 ringpu Main Business Overview
13.7.5 ringpu Latest Developments
13.8 QILU ANIMAL HEALTH PRODUCTS CO.,LTD
13.8.1 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Company Information
13.8.2 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
13.8.3 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Main Business Overview
13.8.5 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Latest Developments
13.9 DAHUANONG
13.9.1 DAHUANONG Company Information
13.9.2 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
13.9.3 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 DAHUANONG Main Business Overview
13.9.5 DAHUANONG Latest Developments
13.10 CAVAC
13.10.1 CAVAC Company Information
13.10.2 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
13.10.3 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 CAVAC Main Business Overview
13.10.5 CAVAC Latest Developments
13.11 Komipharm
13.11.1 Komipharm Company Information
13.11.2 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
13.11.3 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Komipharm Main Business Overview
13.11.5 Komipharm Latest Developments
13.12 Agrovet
13.12.1 Agrovet Company Information
13.12.2 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
13.12.3 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Agrovet Main Business Overview
13.12.5 Agrovet Latest Developments
13.13 Bioveta
13.13.1 Bioveta Company Information
13.13.2 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
13.13.3 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Bioveta Main Business Overview
13.13.5 Bioveta Latest Developments
13.14 JINYU BIO-TECNOLOGY CO.,LTD
13.14.1 JINYU BIO-TECNOLOGY CO.,LTD Company Information
13.14.2 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
13.14.3 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 JINYU BIO-TECNOLOGY CO.,LTD Main Business Overview
13.14.5 JINYU BIO-TECNOLOGY CO.,LTD Latest Developments
13.15 Phibro Animal Health
13.15.1 Phibro Animal Health Company Information
13.15.2 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
13.15.3 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Phibro Animal Health Main Business Overview
13.15.5 Phibro Animal Health Latest Developments
13.16 ANHUI TIANKANG(GROUP)SHRES O., LTD
13.16.1 ANHUI TIANKANG(GROUP)SHRES O., LTD Company Information
13.16.2 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
13.16.3 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 ANHUI TIANKANG(GROUP)SHRES O., LTD Main Business Overview
13.16.5 ANHUI TIANKANG(GROUP)SHRES O., LTD Latest Developments
13.17 Zoetis
13.17.1 Zoetis Company Information
13.17.2 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
13.17.3 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Zoetis Main Business Overview
13.17.5 Zoetis Latest Developments
13.18 WINSUN BIO
13.18.1 WINSUN BIO Company Information
13.18.2 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
13.18.3 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 WINSUN BIO Main Business Overview
13.18.5 WINSUN BIO Latest Developments
13.19 PULIKE BIOLOGICAL ENGINERING,INC.
13.19.1 PULIKE BIOLOGICAL ENGINERING,INC. Company Information
13.19.2 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
13.19.3 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 PULIKE BIOLOGICAL ENGINERING,INC. Main Business Overview
13.19.5 PULIKE BIOLOGICAL ENGINERING,INC. Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Swine Reproductive and Respiratory Syndrome Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Swine Reproductive and Respiratory Syndrome Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Active Vaccine
Table 4. Major Players of Inactivated Vaccines
Table 5. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2017-2022) & (K Units)
Table 6. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Swine Reproductive and Respiratory Syndrome Vaccine Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2017-2022) & (K Units)
Table 11. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2017-2022)
Table 13. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Swine Reproductive and Respiratory Syndrome Vaccine Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Company (2020-2022) & (K Units)
Table 16. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Swine Reproductive and Respiratory Syndrome Vaccine Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Swine Reproductive and Respiratory Syndrome Vaccine Producing Area Distribution and Sales Area
Table 21. Players Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
Table 22. Swine Reproductive and Respiratory Syndrome Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Swine Reproductive and Respiratory Syndrome Vaccine
Table 66. Key Market Challenges & Risks of Swine Reproductive and Respiratory Syndrome Vaccine
Table 67. Key Industry Trends of Swine Reproductive and Respiratory Syndrome Vaccine
Table 68. Swine Reproductive and Respiratory Syndrome Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Swine Reproductive and Respiratory Syndrome Vaccine Distributors List
Table 71. Swine Reproductive and Respiratory Syndrome Vaccine Customer List
Table 72. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Forecast by Region
Table 74. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Swine Reproductive and Respiratory Syndrome Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Swine Reproductive and Respiratory Syndrome Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. ASCENT CORPORATION Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 94. ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. ASCENT CORPORATION Main Business
Table 96. ASCENT CORPORATION Latest Developments
Table 97. Boehringer-Ingelheim Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 99. Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Boehringer-Ingelheim Main Business
Table 101. Boehringer-Ingelheim Latest Developments
Table 102. MSD Animal Health Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 104. MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. MSD Animal Health Main Business
Table 106. MSD Animal Health Latest Developments
Table 107. SPAH Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. SPAH Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 109. SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. SPAH Main Business
Table 111. SPAH Latest Developments
Table 112. Ceva Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Ceva Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 114. Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Ceva Main Business
Table 116. Ceva Latest Developments
Table 117. Chengdu TECH-BANK Biological Products Co,.Ltd Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 119. Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Chengdu TECH-BANK Biological Products Co,.Ltd Main Business
Table 121. Chengdu TECH-BANK Biological Products Co,.Ltd Latest Developments
Table 122. ringpu Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. ringpu Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 124. ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. ringpu Main Business
Table 126. ringpu Latest Developments
Table 127. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 129. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Main Business
Table 131. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Latest Developments
Table 132. DAHUANONG Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 134. DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. DAHUANONG Main Business
Table 136. DAHUANONG Latest Developments
Table 137. CAVAC Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 139. CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. CAVAC Main Business
Table 141. CAVAC Latest Developments
Table 142. Komipharm Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 143. Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 144. Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 145. Komipharm Main Business
Table 146. Komipharm Latest Developments
Table 147. Agrovet Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 148. Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 149. Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 150. Agrovet Main Business
Table 151. Agrovet Latest Developments
Table 152. Bioveta Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 153. Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 154. Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 155. Bioveta Main Business
Table 156. Bioveta Latest Developments
Table 157. JINYU BIO-TECNOLOGY CO.,LTD Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 158. JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 159. JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 160. JINYU BIO-TECNOLOGY CO.,LTD Main Business
Table 161. JINYU BIO-TECNOLOGY CO.,LTD Latest Developments
Table 162. Phibro Animal Health Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 163. Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 164. Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 165. Phibro Animal Health Main Business
Table 166. Phibro Animal Health Latest Developments
Table 167. ANHUI TIANKANG(GROUP)SHRES O., LTD Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 168. ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 169. ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 170. ANHUI TIANKANG(GROUP)SHRES O., LTD Main Business
Table 171. ANHUI TIANKANG(GROUP)SHRES O., LTD Latest Developments
Table 172. Zoetis Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 173. Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 174. Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 175. Zoetis Main Business
Table 176. Zoetis Latest Developments
Table 177. WINSUN BIO Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 178. WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 179. WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 180. WINSUN BIO Main Business
Table 181. WINSUN BIO Latest Developments
Table 182. PULIKE BIOLOGICAL ENGINERING,INC. Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 183. PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 184. PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 185. PULIKE BIOLOGICAL ENGINERING,INC. Main Business
Table 186. PULIKE BIOLOGICAL ENGINERING,INC. Latest Developments
List of Figures
Figure 1. Picture of Swine Reproductive and Respiratory Syndrome Vaccine
Figure 2. Swine Reproductive and Respiratory Syndrome Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Active Vaccine
Figure 10. Product Picture of Inactivated Vaccines
Figure 11. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type in 2021
Figure 12. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Swine Reproductive and Respiratory Syndrome Vaccine Consumed in Government Tender
Figure 14. Global Swine Reproductive and Respiratory Syndrome Vaccine Market: Government Tender (2017-2022) & (K Units)
Figure 15. Swine Reproductive and Respiratory Syndrome Vaccine Consumed in Market Sales
Figure 16. Global Swine Reproductive and Respiratory Syndrome Vaccine Market: Market Sales (2017-2022) & (K Units)
Figure 17. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2017-2022)
Figure 18. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application in 2021
Figure 19. Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Company in 2021
Figure 21. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Geographic Region in 2021
Figure 23. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region (2017-2022)
Figure 24. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country/Region in 2021
Figure 25. Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales 2017-2022 (K Units)
Figure 26. Americas Swine Reproductive and Respiratory Syndrome Vaccine Revenue 2017-2022 ($ Millions)
Figure 27. APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales 2017-2022 (K Units)
Figure 28. APAC Swine Reproductive and Respiratory Syndrome Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales 2017-2022 (K Units)
Figure 30. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country in 2021
Figure 34. Americas Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country in 2021
Figure 35. United States Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region in 2021
Figure 40. APAC Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Regions in 2021
Figure 41. China Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country in 2021
Figure 48. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country in 2021
Figure 49. Germany Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country in 2021
Figure 56. Egypt Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Swine Reproductive and Respiratory Syndrome Vaccine in 2021
Figure 62. Manufacturing Process Analysis of Swine Reproductive and Respiratory Syndrome Vaccine
Figure 63. Industry Chain Structure of Swine Reproductive and Respiratory Syndrome Vaccine
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
